Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis (original) (raw)

Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature

Tulin Ergun

Dermatology Online Journal, 2017

View PDFchevron_right

The efficacy and safety of tofacitinib in patients with alopecia totalis

Dogan Bayram

Journal of the American Academy of Dermatology, 2018

View PDFchevron_right

Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study

Cheng Zhou

Frontiers in Medicine

View PDFchevron_right

Effective treatment of alopecia universalis with oral tofacitinib: A case report

Amnah N Almulhim

Our Dermatology Online, 2021

View PDFchevron_right

Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo

George Varigos

Clinical and experimental dermatology, 2017

View PDFchevron_right

Acne exacerbation after tofacitinib treatment for alopecia areata

Mohammed G Turkmani

Dermatology Reports, 2021

View PDFchevron_right

Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series

Soyun Cho

Journal of the American Academy of Dermatology, 2017

View PDFchevron_right

A Novel Hope for Alopecia Totalis Patients: Case Report

laila otaibi

Dubai Medical Journal, 2020

View PDFchevron_right

Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis

William Sandborn

View PDFchevron_right

Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients

Zekayi Kutlubay

Dermatologic Therapy, 2019

View PDFchevron_right

Alopecia areata in patients with inflammatory bowel disease: an overview

Maria Wiśniewska-Jarosińska

Folia medica Cracoviensia, 2016

View PDFchevron_right

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

Dahong Yu

The New England journal of medicine, 2017

View PDFchevron_right

Alopecia Areata Universalis during Treatment of Rheumatoid Arthritis with Anti-TNF-α Antibody (Adalimumab)

BENOIT BENSAID

Dermatology, 2008

View PDFchevron_right

Ixekizumab-induced alopecia areata

Christopher Bunick

JAAD Case Reports

View PDFchevron_right

Efficacy and Safety of Tofacitinib for Treatment of Moderate to Severe Active Ulcerative Colitis: First Report from Iran

Homayoon Vahedi

Archives of Iranian medicine, 2021

View PDFchevron_right

Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID‐19 pandemic

defne özkoca

Dermatologic Therapy, 2021

View PDFchevron_right

Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata

N. Andreu

British Journal of Dermatology, 2018

View PDFchevron_right

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

Abraham Zlotogorski

EBioMedicine, 2015

View PDFchevron_right

Baricitnib: from rheumatoid arthritis to alopecia areata

Omer Ahmed Shaikh

Journal of Pakistan Medical Association, 2022

View PDFchevron_right

2015 DOJ _ H Toda-Brito _ Adalimumab-induced psoriatic alopecia.pdf

Luis Soares-de-Almeida

View PDFchevron_right

Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study

Fábio V. Teixeira

Crohn's & Colitis 360

View PDFchevron_right

Alopecia universalis during treatment with leflunomide and adalimumab - Case report

Rute facchini lellis

Anais Brasileiros de Dermatologia, 2014

View PDFchevron_right

Alopecia secondary to anti-tumor necrosis factor-alpha therapy

Lara Ribeiro

Anais Brasileiros de Dermatologia, 2015

View PDFchevron_right

Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports

Syed Atiqul Haq

Journal of Medical Case Reports

View PDFchevron_right

The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata

Ronda Farah

International Society of Hair Restoration Surgery

View PDFchevron_right

Successful treatment of alopecia totalis with hydroxychloroquine: Report of 2 cases

Roland Tomb

Journal of The American Academy of Dermatology, 2013

View PDFchevron_right

Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program

Gosford Sawyerr

Inflammatory Bowel Diseases

View PDFchevron_right

Tofacitinib for the treatment of moderate-to-severe psoriasis

Maria Sole Chimenti

Expert Review of Clinical Immunology, 2015

View PDFchevron_right

Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review

Anurag Sachan

Inflammatory Bowel Diseases, 2021

View PDFchevron_right

Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction

Raksawan Deenonpoe

Archives of Dermatological Research, 2017

View PDFchevron_right

Study of Tofacitinib in Refractory Dermatomyositis: An Open‐Label Pilot Study of Ten Patients

Lisa Christopher-stine

Arthritis & Rheumatology, 2021

View PDFchevron_right

Successful initial high-dose tofacitinib treatment for acute severe ulcerative colitis with steroid resistance: A case series

Naoshi Nishida

Research Square (Research Square), 2022

View PDFchevron_right

Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report

Cathryn Sibbald

SAGE Open Medical Case Reports

View PDFchevron_right

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Valderilio F Azevedo

The New England journal of medicine, 2017

View PDFchevron_right

Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy

Monika Slowinska

Journal of Dermatological Case Reports, 2010

View PDFchevron_right